ANHYDROUS SUSPENDIT® (30-5176)


Need this product? We can help. Click below to create your free PCCA account, and access the industry’s highest quality chemicals, devices, equipment and more.
Register

Important Message
As of September 2024, SuspendIt Anhydrous is known as Anhydrous SuspendIt. The name change is designed to help our members’ pharmacy staff more easily differentiate products on the shelf.

For self-emulsifying, longer lasting and better tasting oral suspension formulations

Anhydrous SuspendIt oral suspending vehicle offers improved taste, broader application and prolonged default beyond use dates (BUDs). It is Ideal for active pharmaceutical ingredients (APIs) that are unstable in water or have incompatibilities in some aqueous vehicles.

Learn how this innovative oral suspension can help your patients.

Its unique self-emulsifying system may improve solubility, dispersibility and absorption of APIs, while its thixotropic effect offers rapid redispersion of APIs with minimal sedimentation. And with water activity less than 0.6 (Aw<0.6), Anhydrous is classified as an anhydrous oral vehicle that, depending on the API used, allows pharmacy compounders to assign longer default BUDs.

Unlike traditional fixed oil suspensions and other oral anhydrous suspensions, Anhydrous SuspendIt mixes easily with water or juice to improve patient compliance. Mixing a single dose of the compounded medication with juice or other flavored liquids at time of administration helps disguise the medication’s taste, which may possibly improve medication compliance in children, hospice patients and pets.

Anhydrous SuspendIt is compatible with polyurethane nasogastric (feeding) tubes for use in hospice, pediatric care and other healthcare settings.

Check out the Anhydrous SuspendIt product webinar for more information.

Unique Characteristics
of Anhydrous SUSPENDIT

Anhydrous SuspendIt is unlike any other oral suspension vehicle:

  • Self-emulsifying properties may improve the solubility, dispersibility and possibly enhance bioavailability of drugs with poor water-solubility.
  • Thixotropic effect potentially allows rapid redispersion of APIs upon agitation with potentially minimal sedimentation.
  • Extended BUDs for pharmacy and patient convenience.
  • May use with hydrophilic or lipophilic drugs.
  • Naturally sweetened with monk fruit for a more palpable taste.
  • Preservative free.
  • Offers improved palatability from traditional oil vehicles.
  • Mixes easily with water or juice.
  • Ideal for use in pediatrics, including neonates.
  • Appropriate for vet use (assess to ensure appropriate for the animal’s species).
  • Can be used in polyurethane nasogastric (feeding) tubes.

Self-Emulsifying Drug Delivery System (SEDDS)

  • Combines surfactants within an anhydrous oral vehicle.
  • Provides smaller and more uniform emulsion droplet sizes to help promote the potential for improved absorption and bioavailability.
  • May be used with hydrophilic or lipophilic drugs. The self-emulsifying properties may improve the solubility, dispersibility and possibly enhance bioavailability of APIs with poor water-solubility.
  • Easily mixes with water or juice without the need of additional surfactants or emulsifying agents.

Thixotropic Effects

  • Thins when shaken and thickens upon standing
  • Allows rapid redispersion of APIs with agitation and minimizes sedimentation

Compounding Benefits
of Anhydrous SUSPENDIT

  • Broad application
    Anhydrous SuspendIt is compatible with a broad number of APIs. It is suitable for pharmacies that compound for pediatrics, hospice and geriatric patients, as well as for veterinarians.
  • Improved quality
    Its unique self-emulsifying system improves solubility, dispersibility and absorption of APIs, while its thixotropic effect offers rapid redispersion of APIs with minimal sedimentation.
  • Maximized efficiencies
    Longer default BUDs save compounders time and may increase operational efficiencies for compounders who create anticipatory compounding and batches.
  • Increase patient compliance
    Its natural sweetness and pleasant mouth feel may improve patient satisfaction and compliance. Combined with an ability to mix with water and juice, Anhydrous SuspendIt may help medication taste better for children, pets and other patients.

Patient Benefits
of Anhydrous SUSPENDIT

  • Better tasting
    Its natural sweetness and pleasant mouth feel provides improved palatability over traditional oil vehicles, improving patient satisfaction and medication compliance.
  • Easy preparation
    Can easily mix with water or juice, if preferred, when it’s time to take medication.
  • More convenience
    Prolonged BUDs mean fewer trips to the pharmacy for medication refills.

Related Specialties of Anhydrous SUSPENDIT

Anhydrous SuspendIt is an ideal vehicle when compounding formulations for:

  • Pediatrics
  • Family practice
  • Geriatrics
  • Health Systems
  • Hospice
  • Veterinary medicine

Nutritional Facts of Anhydrous SUSPENDIT

For Anhydrous SuspendIt Oral Base Only

Protein 0.3%
Fat 87.7%
Carbohydrates 7.7%
Calories 821 Cal/100 gm

Formulated without*

Gluten
Wheat
Corn
Sucrose
Glucose
Fructose
Lactose
Maltose
Crustacean
Soy
Walnut
Sesame
Pecan
Peanut
Almond
Hazelnut
Macadamia
Tree nut
Egg
Milk
Fish

*Based on manufacturer lot

Frequently Asked Questions about Anhydrous SUSPENDIT

Is Anhydrous SuspendIt safe for use in animals?

Yes, the ingredients are safe for use in animals; however, in animals with pancreatitis, the use of any anhydrous vehicle that contains MCT or other fixed oil is not recommended. Additional caution must be exercised for use in certain animal species — such as birds — to ensure the formula/vehicle is appropriate for the species

Does Anhydrous SuspendIt replace PCCA Fixed Oil Suspension Vehicle for oral suspension formulations?

While our Fixed Oil Suspension Vehicle is a well-established oral suspension, Anhydrous SuspendIt is a new anhydrous option to consider when starting a patient on an oral suspension formula. If a patient and their prescriber are pleased with their current compounded medication, we recommend not changing that compound formulation.

Should pharmacy compounders transition patients who are using other oral suspension bases to Anhydrous SuspendIt?

It depends on the situation. Anhydrous SuspendIt is a great option when starting a new patient on an oral suspension formulation. In the same respect, if a patient is experiencing issues with their current medication, changing the base instead of the dose may be a good option. However, if a patient and their prescriber are pleased with the current compounded medication, including taste and compliance, we recommend not changing.

What are the suggested compounding procedures when working with this base?

We suggest referring to PCCA’s formula #14432 Oral Suspension — General Formula (Anhydrous SuspendIt) — to use as a guide when developing new formulas. We also recommend all formulas are mixed using an electronic mortar and pestle (EMP) for two (2) minutes on a medium setting, then transferred to an appropriate-sized dispensing container. Due to the viscosity of the preparation, using the EMP mixing method will help obtain optimal content uniformity.

Could you dilute the dose before administration?

Some patients may be more sensitive to the ‘mouth feel’ or minor throat irritation of an anhydrous base; therefore, diluting the single dose with juice or water at time of administration is an option.

Is Anhydrous SuspendIt appropriate for use in patients on ketogenic (Keto) diets?

We recommend reviewing the Nutritional Facts to determine appropriate use for an individual patient. Anhydrous SuspendIt contains approximately 1.54 calories per 5 mL from carbohydrates.

What is the max powder load?

Because of the viscosity of Anhydrous SuspendIt, approximately 10% (100 mg/mL) is the max powder load. To date, formulations with a powder load over 10% have not been tested. Should you have a need to make such a formulation, we recommend you engage in appropriate testing of the formulation prior to proceeding.

Is a wetting agent required in the formulation?

The use of wetting agents often depends on the API. Some agents that could be used with Anhydrous SuspendIt are Glycerin USP or Medium Chain Triglycerides NF; however, the majority of the formulas use the base itself as the wetting agent.

Is it necessary to dispense with SealSafe® 24MM Self-Sealing Dosing Adapter (PCCA #35-4262) as noted in the formula procedure?

Yes, it is advised to dispense with the self-sealing adapter. Since formulas are viscous, using these adapters prevents buildup of suspension in the neck of the dispensing container and reduces the potential loss of dosages.

Can other adapta-caps be used instead of the SealSafe Self-Sealing Dosing Adapters?

No. We recommend using only the Seal-Safe Self-Sealing Dosing Adapters because they fit within the neck of the dispensing bottle. Other adapta-caps fit on the top threading of the bottle and do not seal the inner neck to prevent buildup.

Can aqueous flavors be used and would they impact the USP default BUD?

Yes, aqueous flavors may be used in Anhydrous SuspendIt up to 3% and water activity testing remained under 0.6. The addition of an emulsifier is not required due to the self-emulsifying properties of the base. The exception is with concentrate flavors as they are not compatible with the base.

What types of nasogastric (feeding) tubes may be used with Anhydrous SuspendIt?

Anhydrous SuspendIt tests were conducted only in nasogastric polyurethane (feeding) tubes. After administering 5 mL suspension, the tube was flushed with 10 mL purified water. No significant residues or clogging were seen. Nasogastric (feeding) tubes constructed with other materials were, to date, not tested. We strongly recommend knowing the nasogastric (feeding) tube material prior to administering.

Can this base be used in oil-filled capsule formulas?

Yes, this is an anhydrous suspension base that can be used to create oil filled capsules. See PCCA Formula #14401 – General Formula, Anhydrous SuspendIt Capsules Size #1.

Does an anhydrous vehicle provide stability for all preparations?

No. Anhydrous bases decrease hydrolysis and microbial growth, but some APIs may still be susceptible to oxidation.

Does temperature affect the base or compounded formulation?

Temperatures over 35°C may affect the base. High temperatures may cause the solid ingredients to reach their melting point; therefore, the base becomes a clear solution. Once the base returns to room temperature, the emulsion system could separate. This may occur during shipping — notably if the base or formulation is exposed to high temperatures. Low temperatures, including refrigeration, do not impact the base.

Why does the label state “Shake well before use”?

Given the system is halfway between an emulsion and a suspension system, some natural separation may occur over time. Monk fruit is not soluble; due to this, you may see some visible particles prior to shaking well. Anhydrous SuspendIt is packaged to allow additional head space for adequate shaking, which in turn allows re-suspension of the base vehicle. Additional head space should also be given to compounded preparations.

What is the specific gravity of Anhydrous SuspendIt?

Approximately 0.96.

Always make sure you have checked the PCCA Formula Database and are following the most up-to-date version of a formula, as changes are continuously made to existing formulations to provide the highest quality. The formulas and/or statements listed are provided for educational purposes only. They are compounding ideas that have commonly been requested by physicians and have not been evaluated by the Food and Drug Administration. Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

  • Warm Weather Shipping From May through September, this product will ship with insulated liner and ice packs to maintain room temperature during warm weather transport. This product will only ship from PCCA from Monday through Wednesday, using ground shipping. No refrigeration is required; store product at room temperature. Normal shipping processes resume October 1.
  • Department of Transportation (DOT) In accordance with DOT : Not applicable

Caution: *Shake well before use.* PATENT PENDING - FOR USE AS AN EXCIPIENT

Test Specification
DESCRIPTION WHITE TO FAINT BEIGE VISCOUS LIQUID WITH CHARACTERISTIC ODOR
SPECIFIC GRAVITY 0.90-1.10
VISCOSITY 150-1200 CP